152 related articles for article (PubMed ID: 10601683)
1. In vitro assessment of archaeosome stability for developing oral delivery systems.
Patel GB; Agnew BJ; Deschatelets L; Fleming LP; Sprott GD
Int J Pharm; 2000 Jan; 194(1):39-49. PubMed ID: 10601683
[TBL] [Abstract][Full Text] [Related]
2. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
Patel GB; Sprott GD
Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
[TBL] [Abstract][Full Text] [Related]
3. Safety of archaeosome adjuvants evaluated in a mouse model.
Patel GB; Omri A; Deschatelets L; Sprott GD
J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
[TBL] [Abstract][Full Text] [Related]
4. Influence of coenzyme Q10 on tissue distribution of archaeosomes, and pegylated archaeosomes, administered to mice by oral and intravenous routes.
Omri A; Makabi-Panzu B; Agnew BJ; Sprott GD; Patel GB
J Drug Target; 2000; 7(5):383-92. PubMed ID: 10721800
[TBL] [Abstract][Full Text] [Related]
5. Archaeal lipids in oral delivery of therapeutic peptides.
Jacobsen AC; Jensen SM; Fricker G; Brandl M; Treusch AH
Eur J Pharm Sci; 2017 Oct; 108():101-110. PubMed ID: 28108360
[TBL] [Abstract][Full Text] [Related]
6. Archaeosome immunostimulatory vaccine delivery system.
Patel GB; Chen W
Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
[TBL] [Abstract][Full Text] [Related]
7. A structural comparison of the total polar lipids from the human archaea Methanobrevibacter smithii and Methanosphaera stadtmanae and its relevance to the adjuvant activities of their liposomes.
Sprott GD; Brisson J; Dicaire CJ; Pelletier AK; Deschatelets LA; Krishnan L; Patel GB
Biochim Biophys Acta; 1999 Sep; 1440(2-3):275-88. PubMed ID: 10521711
[TBL] [Abstract][Full Text] [Related]
8. Short-term repeated-dose toxicity profile of archaeosomes administered to mice via intravenous and oral routes.
Omri A; Agnew BJ; Patel GB
Int J Toxicol; 2003; 22(1):9-23. PubMed ID: 12573945
[TBL] [Abstract][Full Text] [Related]
9. Lateral diffusion of the total polar lipids from Thermoplasma acidophilum in multilamellar liposomes.
Jarrell HC; Zukotynski KA; Sprott GD
Biochim Biophys Acta; 1998 Mar; 1369(2):259-66. PubMed ID: 9518643
[TBL] [Abstract][Full Text] [Related]
10. New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery.
Benvegnu T; Lemiègre L; Cammas-Marion S
Recent Pat Drug Deliv Formul; 2009 Nov; 3(3):206-20. PubMed ID: 19534669
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
[TBL] [Abstract][Full Text] [Related]
12. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
Sprott GD; Sad S; Fleming LP; Dicaire CJ; Patel GB; Krishnan L
Archaea; 2003 Oct; 1(3):151-64. PubMed ID: 15803661
[TBL] [Abstract][Full Text] [Related]
13. Stability of pressure-extruded liposomes made from archaeobacterial ether lipids.
Choquet CG; Patel GB; Beveridge TJ; Sprott GD
Appl Microbiol Biotechnol; 1994 Nov; 42(2-3):375-84. PubMed ID: 7765779
[TBL] [Abstract][Full Text] [Related]
14. Salt tolerance of archaeal extremely halophilic lipid membranes.
Tenchov B; Vescio EM; Sprott GD; Zeidel ML; Mathai JC
J Biol Chem; 2006 Apr; 281(15):10016-23. PubMed ID: 16484230
[TBL] [Abstract][Full Text] [Related]
15. Coenzyme Q10 in vesicles composed of archaeal ether lipids or conventional lipids enhances the immuno-adjuvanticity to encapsulated protein.
Makabi-Panzu B; Sprott GD; Patel GB
Vaccine; 1998 Oct; 16(16):1504-10. PubMed ID: 9711796
[TBL] [Abstract][Full Text] [Related]
16. Archaeosomes as novel antigen delivery systems.
Sprott GD; Tolson DL; Patel GB
FEMS Microbiol Lett; 1997 Sep; 154(1):17-22. PubMed ID: 9297816
[TBL] [Abstract][Full Text] [Related]
17. Archaeosomes with encapsulated antigens for oral vaccine delivery.
Li Z; Zhang L; Sun W; Ding Q; Hou Y; Xu Y
Vaccine; 2011 Jul; 29(32):5260-6. PubMed ID: 21609747
[TBL] [Abstract][Full Text] [Related]
18. Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids.
Parmentier J; Becker MM; Heintz U; Fricker G
Int J Pharm; 2011 Feb; 405(1-2):210-7. PubMed ID: 21145956
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization, and in vitro evaluation of isoniazid and rifampicin-loaded archaeosomes.
Attar A; Bakir C; Yuce-Dursun B; Demir S; Cakmakci E; Danis O; Birbir M; Ogan A
Chem Biol Drug Des; 2018 Jan; 91(1):153-161. PubMed ID: 28667670
[TBL] [Abstract][Full Text] [Related]
20. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
